发现好书期刊,享受阅读乐趣

海量图书期刊资源,随时随地畅享阅读乐趣

Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib

Everolimus: the first approved product for patients with advanced renal cell cancer after sunitinib and/or sorafenib

Coppin, Chris
  • 期刊名称Biologics: Targets & Therapy
  • 作者Coppin, Chris
  • 电子ISSN1177-5475
  • 文件大小647.84KB
  • 发表时间2010-04
  • DOI10.2147/btt.s6748
← 返回【学霸图书馆】主页